HR Pharmaceuticals announced that it entered into an exclusive commercial agreement with Poiesis Medical to license catheter technology. The deal centers around Poiesis' dual-balloon catheter, the Duette system. Under the terms, HR Pharmaceuticals has exclusive commercialization rights to Duette in North America. The deal expands HR … [Read more...] about HR Pharmaceuticals licenses dual-balloon catheter tech from Poiesis Medical
Catheters
Catheter-based innovations we can’t stop thinking about
Catheter-based devices had their year in 2023. Medtech companies set their sights on improving patient care in cardiology, neurology and more. Our previous roundup of the top 10 most-read catheter-based news stories of 2023 wasn't enough for us. Medical Tubing + Extrusion's editors could not stop thinking about several other stories when … [Read more...] about Catheter-based innovations we can’t stop thinking about
The 10 most-read catheter-based innovation stories of 2023
This year was a year of firsts for catheter-based innovations, most notably for renal denervation and pulsed field ablation. ReCor Medical won an FDA panel nod for its renal denervation system in August. The panel voted in favor of the safety and efficacy of its Paradise ultrasound renal denervation (RDN) system for treating hypertension. The … [Read more...] about The 10 most-read catheter-based innovation stories of 2023
FDA clears neurovascular aspiration, access catheters from Perfuze
Perfuze announced today that the FDA cleared its Millipede 070 aspiration catheter and second-generation Millipede 088 access catheter. Galway, Ireland-based Perfuze developed Millipede 070 to address critical unmet needs in ischemic stroke treatment. It aims to remove clots rapidly and safely through a novel, unique catheter. Millipede 070 … [Read more...] about FDA clears neurovascular aspiration, access catheters from Perfuze
Pulse Biosciences announces first human use of pulsed-field ablation catheter
Pulse Biosciences (Nasdaq:PLSE) today announced the completion of the first-in-human procedures for its CellFX nsPFA cardiac catheter. The Hayward, California-based company completed the first five procedures in its first-in-human feasibility study. Treating physicians successfully discharged all patients. They'll continue to be monitored and … [Read more...] about Pulse Biosciences announces first human use of pulsed-field ablation catheter
What’s so special about pulsed field ablation? Medtronic EVP Sean Salmon explains
Medtronic’s PulseSelect Pulsed Field Ablation (PFA) System — which won the first FDA approval for PFA to treat atrial fibrillation (AFib) — is just the start of a wave of new PFA devices expected to hit the market. Medtronic is lining up another PFA cardiac ablation system for approval, while competitor Boston Scientific anticipates approval of … [Read more...] about What’s so special about pulsed field ablation? Medtronic EVP Sean Salmon explains
B. Braun launches luer device for IV infusions
B. Braun Medical announced that it launched its new CareSite Micro luer access device designed to make IV access safer. Bethlehem, Pennsylvania-based B. Braun designed the device to reduce exposure to harmful chemicals. It aims to decrease infection risk in IV access for patients and healthcare providers. The company says its device is the … [Read more...] about B. Braun launches luer device for IV infusions
Cerenovus President Mark Dickinson on the future of stroke care
Cerenovus President Mark Dickinson forecasts the innovative technologies that will advance stroke care in the coming years. It's getting harder to beat aspiration systems for fast and simple thrombectomies to remove blood clots that are blocking oxygen from a stroke patient's brain. That's according to Cerenovus Worldwide President Mark … [Read more...] about Cerenovus President Mark Dickinson on the future of stroke care
Medtronic PulseSelect pulsed field ablation wins FDA approval
The FDA has approved the Medtronic PulseSelect pulsed field ablation (PFA) system, the device developer said today. PulseSelect is the first PFA technology approved for use in the U.S., as well as the first PFA technology with FDA breakthrough designation to win approval. The minimally invasive, cardiac ablation system is indicated for the … [Read more...] about Medtronic PulseSelect pulsed field ablation wins FDA approval
J&J’s Biosense Webster treats first patients in dual-energy AFib ablation trial
Johnson & Johnson's Biosense Webster today announced the first completed patient cases in a study of its dual-energy ablation catheter. Biosense Webster designed the ThermoCool SmartTouch SF to deliver both radiofrequency (RF) and pulsed-field ablation (PFA) energy. The SmartPulse pivotal study evaluates the dual-energy system in the … [Read more...] about J&J’s Biosense Webster treats first patients in dual-energy AFib ablation trial